Skip to content
Lifestyle & Learning

1 ICD-10 Code for Mixed Alzheimer's and Vascular Dementia Explained: Coding and Documentation Guide for 2026

In this article

To accurately report a diagnosis of mixed Alzheimer’s and vascular dementia in 2026, medical coders must use a combination of two codes rather than a single standalone code. The required sequence begins with G30.9 (Alzheimer's disease, unspecified) followed by a code from the F01 series (Vascular dementia), such as F01.50 or the more specific severity-based codes like F01.A11.

The complexity of coding mixed dementia stems from the way the International Classification of Diseases, 10th Revision (ICD-10), separates physical neurological conditions from their mental and behavioral manifestations. Because mixed dementia involves two distinct underlying pathologies—neurodegenerative protein aggregation and cerebrovascular damage—the ICD-10-CM (Clinical Modification) guidelines mandate a "code first" approach to ensure both the cause and the symptoms are captured for clinical and statistical purposes.

Understanding the "Code First" Convention for Mixed Dementia

The primary reason there is no single "1 ICD-10 code" for mixed dementia is the etiology/manifestation convention used throughout the ICD-10 system. In medical coding, many conditions are structured so that the underlying disease (etiology) is recorded first, and the resulting condition (manifestation) is recorded second.

For mixed Alzheimer’s and vascular dementia, Alzheimer’s disease is categorized under Chapter 6 (Diseases of the Nervous System), while vascular dementia and its behavioral components fall under Chapter 5 (Mental, Behavioral, and Neurodevelopmental Disorders).

In 2026, documentation must clearly distinguish between these two forces. Alzheimer’s disease (G30.x) represents the primary neurodegenerative process, while the vascular component (F01.x) describes the cognitive impairment resulting from stroke, small vessel disease, or other ischemic events. When a physician documents "Mixed Dementia" or "Mixed Alzheimer's and Vascular Dementia," the coder is instructed by the ICD-10-CM Tabular List to sequence the G30 code first, followed by the F01 code.

The Primary Component: Alzheimer’s Disease (G30 Series)

The first step in the coding sequence is identifying the specific type of Alzheimer’s disease. While many clinicians simply write "Alzheimer's," more specific documentation allows for more accurate coding, which is essential for risk adjustment and longitudinal care tracking.

G30.0: Alzheimer’s Disease with Early Onset

This code is used when the disease manifests before the age of 65. It often implies a more rapid progression and may involve specific genetic markers. In a mixed dementia diagnosis, if the Alzheimer’s component began early, G30.0 would be the lead code.

G30.1: Alzheimer’s Disease with Late Onset

This is the most common form of the disease, appearing in patients 65 and older. In 2026, as the population continues to age, G30.1 is frequently paired with vascular codes, as vascular health typically declines with age alongside neurodegeneration.

G30.9: Alzheimer’s Disease, Unspecified

If the medical record does not specify the age of onset or specific subtype, G30.9 is the default primary code for the Alzheimer’s portion of a mixed dementia diagnosis. Even though it is "unspecified," it remains the critical anchor for the diagnosis.

ICD 10 Code APK for Android Download
ICD 10 Code APK for Android Download

The Secondary Component: Vascular Dementia (F01 Series)

Once the Alzheimer’s code is established, the coder must add the code for the vascular component. This is where the coding becomes more granular in 2026, following updates that emphasize the severity of the cognitive impairment and the presence of behavioral disturbances.

The F01 series is titled "Vascular dementia." Within this category, several sub-codes exist to describe the clinical picture:

  1. F01.50: Vascular dementia without behavioral disturbance.
  2. F01.51: Vascular dementia with behavioral disturbance (e.g., wandering, aggression, or combativeness).
  3. F01.A Series: Vascular dementia, unspecified severity.
  4. F01.B Series: Vascular dementia, mild.
  5. F01.C Series: Vascular dementia, moderate.
  6. F01.D Series: Vascular dementia, severe.

For a patient with mixed dementia who exhibits moderate cognitive decline and agitated behavior, the correct sequence would be G30.9 followed by F01.C11 (Vascular dementia, moderate, with agitation).

Coding Mixed Alzheimer's and Vascular Dementia: A Comparison Table

The following table outlines the most common code combinations used for mixed dementia based on the standard 2026 ICD-10-CM guidelines.

Diagnosis Detail Primary Code (Etiology) Secondary Code (Manifestation/Severity) Full Coding Sequence
Mixed Dementia, Unspecified G30.9 F01.50 G30.9, F01.50
Mixed Dementia with Agitation G30.9 F01.51 G30.9, F01.51
Late-onset Mixed (Mild) G30.1 F01.B0 G30.1, F01.B0
Early-onset Mixed (Severe) G30.0 F01.D0 G30.0, F01.D0
Mixed with Depression G30.9 F01.511 G30.9, F01.511

Note: The codes in the F01.A-D series often require additional characters to specify the exact behavioral manifestation, such as anxiety, mood disorders, or psychotic features.

Why One Code (F03) Is Usually Incorrect

Many healthcare providers mistakenly use F03.90 (Unspecified dementia, without behavioral disturbance) to represent mixed dementia. While this is technically a single code, it is clinically and administratively insufficient in 2026 for a diagnosis of mixed Alzheimer's and vascular dementia.

F03 is a "catch-all" category for dementia where the underlying cause is unknown. If the physician has specifically identified Alzheimer’s and vascular components, using F03 ignores the specificity of the diagnosis. This can lead to:

  • Loss of Revenue: Many Medicare Advantage and private insurance plans use Hierarchical Condition Categories (HCCs) for reimbursement. Alzheimer's (G30) and Vascular Dementia (F01) carry higher risk scores than unspecified dementia (F03).
  • Poor Care Coordination: Specialists (neurologists and psychiatrists) need to know the specific pathologies to manage medications like cholinesterase inhibitors versus blood pressure management for vascular health.
  • Inaccurate Data: Public health records rely on accurate coding to track the prevalence of mixed dementia versus pure Alzheimer’s.

Clinical Documentation Requirements in 2026

For a coder to accurately assign the dual codes for mixed dementia, the clinician’s documentation must be robust. In 2026, auditors look for specific clinical indicators that justify the use of both G30 and F01.

Evidence of Alzheimer’s Pathophysiology

Documentation should note the presence of progressive memory loss, executive dysfunction, and ideally, biomarkers or imaging (such as PET scans or CSF analysis) showing amyloid plaques and tau tangles, although a clinical diagnosis based on the NIA-AA criteria is often sufficient.

Evidence of Vascular Contribution

To justify the F01 code, the record must show a relationship between the cognitive decline and cerebrovascular disease. This includes:

  • Imaging (MRI or CT) showing infarcts, lacunae, or extensive white matter lesions (leukoaraiosis).
  • A history of "stair-step" decline (sudden drops in function followed by plateaus), which is characteristic of vascular events.
  • The presence of cardiovascular risk factors like hypertension, diabetes, or atrial fibrillation that are actively contributing to the cognitive state.

Specificity of Behavioral Symptoms

Since the F01 code changes based on behavioral disturbances, the provider must document specific symptoms. Instead of writing "dementia with behaviors," the provider should specify "dementia with wandering," "dementia with verbal aggression," or "dementia with depressive mood." Each of these leads to a more specific 5th or 6th character in the F01 series.

Financial and Administrative Impact of Accurate Coding

In the current 2026 healthcare landscape, the accuracy of coding mixed dementia directly impacts the financial viability of geriatric practices and the quality scores of healthcare systems.

Hierarchical Condition Categories (HCC)

Mixed dementia codes are highly relevant for Medicare Advantage (Part C) risk adjustment. G30.x and F01.x both map to significant HCC categories. By using the specific dual-code sequence instead of a single unspecified code, the patient’s "Risk Adjustment Factor" (RAF) score accurately reflects the complexity of their care. This ensures that the healthcare provider receives appropriate funding to manage a patient who requires both neurological and cardiovascular monitoring.

Quality Measures (MIPS and HEDIS)

Quality reporting programs often track the management of patients with specific dementia diagnoses. Accurate coding ensures that patients are correctly included in or excluded from specific quality cohorts, such as medication review for high-risk elderly patients or cognitive assessment benchmarks.

Common Pitfalls and How to Avoid Them

Even experienced coders can stumble when dealing with mixed dementia due to the overlapping nature of the symptoms.

  1. Over-relying on the term "Dementia": If a doctor writes "Mixed Dementia," don't default to F03. Search the chart for "Alzheimer's" and "Vascular" to see if the specific components are identified.
  2. Ignoring the "Code First" Note: In the ICD-10-CM manual, under category F01, there is a clear instruction: "Code first the underlying physiological condition." If you reverse the order (putting F01 before G30), the claim may be denied.
  3. Missing New Behavioral Codes: Ensure you are using the updated 2026 expansions for behavioral disturbances. The F01.51 code is now often expanded (F01.511, F01.518, etc.) to provide more detail on the type of behavior.
  4. Failure to Update After New Testing: Often, a patient is initially coded with F03 (unspecified) but later receives an MRI or specialty consult that confirms mixed Alzheimer's and vascular disease. The coding should be updated to reflect the higher specificity as soon as the documentation supports it.

Frequently Asked Questions

Is there a single ICD-10 code for mixed dementia in 2026?

No. There is no single code. You must use the dual-code sequence: G30.9 (or other G30 codes) followed by the appropriate F01 code to capture both the Alzheimer's and vascular components.

Which code should be sequenced first?

The G30 (Alzheimer's) code must always be sequenced first as the etiology, while the F01 (Vascular dementia) code is sequenced second as the manifestation/behavioral component.

Can I code mixed dementia if only one component is mentioned?

No. To code mixed Alzheimer's and vascular dementia, the physician must explicitly document both conditions or use the term "Mixed Dementia" with supporting evidence of both pathologies in the record.

What if the patient has Alzheimer’s and another type of dementia, like Lewy Body?

This follows a similar rule. You would code G30.9 for Alzheimer’s and G31.83 for Dementia with Lewy Bodies. This further emphasizes that dementia coding in 2026 is moving toward multi-code specificity rather than "one-size-fits-all" codes.

Does the behavioral disturbance code (F01.51) apply to the Alzheimer's component too?

Yes. When you use the G30 + F01 sequence, the F01.51 code effectively captures the behavioral manifestations of the patient's overall cognitive state, even if the behaviors are partly driven by the Alzheimer's pathology.

Practical Recommendation for 2026

For clinicians and coding professionals in 2026, the goal is specificity. When encountering a patient with mixed dementia:

  1. Identify the Alzheimer's onset: Is it early (G30.0) or late (G30.1)?
  2. Assess the Vascular severity: Is the cognitive impairment mild (F01.B), moderate (F01.C), or severe (F01.D)?
  3. Document Behaviors: Note specific disturbances like agitation or depression to select the correct 5th and 6th characters.
  4. Sequence Correctly: Always place the G30 code in the primary position.

By following this "Code First" methodology, you ensure clinical accuracy, maximize reimbursement through appropriate HCC mapping, and provide a clear roadmap for the patient's long-term care management.